share_log

Johnson & Johnson's (NYSE:JNJ) Investors Will Be Pleased With Their Favorable 37% Return Over the Last Five Years

Johnson & Johnson's (NYSE:JNJ) Investors Will Be Pleased With Their Favorable 37% Return Over the Last Five Years

过去五年中,强生(纽交所股票代码:JNJ)的投资者将会为他们获得的令人满意的37%的回报感到高兴。
Simply Wall St ·  08/07 06:33

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than that, you probably want to see it rise more than the market average. Unfortunately for shareholders, while the Johnson & Johnson (NYSE:JNJ) share price is up 19% in the last five years, that's less than the market return. The last year has been disappointing, with the stock price down 8.2% in that time.

当您长期购买并持有股票时,肯定希望它能提供正面的回报。但更重要的是,您可能希望看到它的增长超过市场平均水平。不幸的是,对于股东而言,尽管强生(纽交所:JNJ)股价在过去五年中上涨了19%,但这低于市场回报。过去一年令人失望,股价在这段时间内下跌了8.2%。

Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business.

现在值得更详细地了解该公司的基本面,因为这将帮助我们判断长期股东回报是否与基础业务的表现相匹配。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

虽然市场是一个强大的定价机制,但股价反映的不仅仅是企业的基本业绩,还有投资者的情绪。一个不完美但简单的方式来考虑公司市场意识的变化是比较每股收益(EPS)的变化和股价的变化。

During five years of share price growth, Johnson & Johnson achieved compound earnings per share (EPS) growth of 2.1% per year. This EPS growth is lower than the 4% average annual increase in the share price. This suggests that market participants hold the company in higher regard, these days. And that's hardly shocking given the track record of growth.

在股价增长的五年中,强生公司的每股收益(EPS)复合增长率为2.1%每年。这种EPS增长低于股价平均年增长4%。这表明现今市场参与者更看好该公司。考虑到其增长记录,这并不令人惊讶。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

该公司的每股收益(随时间的推移)如下图所示(单击可查看确切数字)。

big
NYSE:JNJ Earnings Per Share Growth August 7th 2024
纽交所:JNJ每股收益增长2024年8月7日

We know that Johnson & Johnson has improved its bottom line lately, but is it going to grow revenue? If you're interested, you could check this free report showing consensus revenue forecasts.

我们知道强生公司近期已经改善了其底线,但它将增长收入吗?如果您感兴趣,您可以查看这份免费报告以查看共识收入预测。

What About Dividends?

那么分红怎么样呢?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. As it happens, Johnson & Johnson's TSR for the last 5 years was 37%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence!

除衡量股票回报外,投资者还应考虑总股东回报(TSR)。TSR包括任何分拆或折价增资的价值,以及任何据假定股利已被再投资的股息。因此,对于支付丰厚股息的公司,TSR通常比股票回报高得多。事实上,强生公司过去5年的TSR为37%,超过了先前提到的股票回报。而股息付款在很大程度上解释了这种背离情况!

A Different Perspective

不同的观点

Johnson & Johnson shareholders are down 5.3% for the year (even including dividends), but the market itself is up 16%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Longer term investors wouldn't be so upset, since they would have made 6%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 1 warning sign for Johnson & Johnson that you should be aware of before investing here.

强生公司的股东们今年(包括股息)亏损了5.3%,而市场自身上涨了16%。但是,请记住,即使是最好的股票有时也会在十二个月的时间内表现不佳。从更长远的投资者的角度来看,他们在过去五年中每年都会获得6%的回报。如果基本数据继续表明长期可持续的增长,当前的抛售可能值得考虑。虽然考虑到市场条件对股价的不同影响非常值得,但还有其他因素更加重要。例如,我们发现了一种强生公司的1个警告信号,在投资之前应该注意。

But note: Johnson & Johnson may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

但请注意:强生公司可能不是最好的股票购买选择。因此,请查看此过去盈利增长(以及进一步增长预测)有趣的公司的免费列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文所引述的市场回报反映了目前在美国交易所上市的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发